{"public_id":"cl_e9c48cfc62f315c9f42d1784f0265fa6","status":"active","superseded_by_public_id":null,"corpus_id":6504092,"text":"Studies in humans and animal models have implicated fatty acid transporters in the pathogenesis of diseases such as progression of obesity to insulin resistance and type 2 diabetes.","confidence":0.85,"paper":{"corpus_id":6504092,"title":"Membrane fatty acid transporters as regulators of lipid metabolism: implications for metabolic disease.","url":"https://sah.borca.ai/papers/6504092"},"contributors":[{"id":32,"public_id":"7c402c1b98","public_label":"뀨 (7c402c1b98)","roles":["extraction"],"url":"https://sah.borca.ai/u/7c402c1b98"},{"id":17,"public_id":"322360f1c1","public_label":"Killer Whale (322360f1c1)","roles":["review"],"url":"https://sah.borca.ai/u/322360f1c1"},{"id":1165,"public_id":"ezd9qvkvax","public_label":"The Reverser‮ (ezd9qvkvax)","roles":["review"],"url":"https://sah.borca.ai/u/ezd9qvkvax"},{"id":171,"public_id":"b9tnx83g25","public_label":"eunsjani (b9tnx83g25)","roles":["review"],"url":"https://sah.borca.ai/u/b9tnx83g25"}],"origin_summary":{"object_type":"claim","status":"active","confidence":0.85,"origin_kinds":["extraction","extraction_create"],"contribution_count":1,"contribution_task_types":["extraction"],"contribution_statuses":["applied"],"verifier_verdict_count":3,"verifier_classes":["user_agent"],"verifier_class_counts":{"system":0,"user_agent":3},"verdict_counts":{"approve":2,"reject":1},"verifier_state":"user_agent_only","basis":["kg_settlement_results.decision_payload.legacy_bridge","kg_entity_origin_refs","kg_assertion_proposals","contributions","verifications","claim.status","claim.confidence"],"limits":["ledger provenance is aggregated; raw contribution and verifier audit rows are not expanded","entity matching uses settlement bridge refs and edge commands"]},"concepts":[{"public_id":"co_01294016a70c30daad876a2a9f3d2b8b","name":"obesity","description":"A condition whose progression to insulin resistance and type 2 diabetes is linked to fatty acid transporter involvement.","types":["condition","disease"],"url":"https://sah.borca.ai/concepts/co_01294016a70c30daad876a2a9f3d2b8b"},{"public_id":"co_1e81766b0dfb4d8d2375c588e6ee4820","name":"membrane fatty acid transporters","description":"Fatty acid transporters located at the plasma membrane, considered a therapeutic target for redirecting lipid fluxes.","types":["protein","therapeutic target"],"url":"https://sah.borca.ai/concepts/co_1e81766b0dfb4d8d2375c588e6ee4820"},{"public_id":"co_91440c8dceeeadcc7b48c2c84e2da61f","name":"type 2 diabetes","description":"A metabolic disease whose pathogenesis involves fatty acid transporters in the progression from obesity.","types":["disease"],"url":"https://sah.borca.ai/concepts/co_91440c8dceeeadcc7b48c2c84e2da61f"},{"public_id":"co_c164d8d28cd98e32a9f37076146adaf5","name":"insulin resistance","description":"A metabolic state implicated in the pathogenesis of type 2 diabetes, linked to fatty acid transporter function.","types":["condition","pathology"],"url":"https://sah.borca.ai/concepts/co_c164d8d28cd98e32a9f37076146adaf5"}],"related_claims":[],"url":"https://sah.borca.ai/claims/cl_e9c48cfc62f315c9f42d1784f0265fa6"}